San Francisco, CA (PRWEB) March 3, 2009
Cambridge Healthtech Institute's Molecular Medicine Tri-Conference has named five biotech companies that have won the Third Annual Best New Product Awards: The winning products include AnaSpec's ClearPoint Peptides, Accelrys' Pipeline Pilot Cheminformatics Collection, Almac Diagnostics' Ovarian Cancer DSA Research Tool, Seahorse Biosciences' Seahorse XF96 Extracellular Flux Analyzer, and BioFortis' Labmatrix.
One company was selected within five technology categories. Winning products were selected by delegates of the Molecular Medicine Tri-Conference, who voted for products they felt best exemplified innovation in their field. The following winners were selected from 25 finalists.
- Biological Samples & Reagents
ClearPoint Peptides by AnaSpec
Pipeline Pilot Cheminformatics Collection by Accelrys
- Assays & Kits for Basic Research
Ovarian Cancer DSA Research Tool by Almac Diagnostics
- Assays & Kits for Drug Development
Seahorse XF96 Extracellular Flux Analyzer by Seahorse Biosciences
- Discovery Informatics
Labmatrix by BioFortis
Best New Product Award Winners
By spiking protein tryptic digests with internal heavy isotope labeled peptide standards, Mass Spectrometry becomes an absolute quantitation (AQUA) method. With a choice of heavy hydrogen (2H), carbon (13C), or nitrogen (15N)-isotopes specifically labeled at single, multiple or universal positions, ClearPoint™ peptides are an ideal solution for absolute protein quantitation.
Pipeline Pilot Cheminformatics Collection
Accelrys' chemistry-centric List Management and Query Services system (LMQS) enables rapid searching of different data sources that utilize a variety of database search engines and schemas. Results can be automatically organized into lists that can be manipulated within Pipeline Pilot, enabling users to reuse, share, report and analyze their data.
Ovarian Cancer DSA Research Tool
The Ovarian Cancer DSA(TM) research tool is the first high-density disease focused transcriptome based microarray for the study of ovarian. With ~100,000 transcripts derived from ovarian tissue, the Ovarian cancer DSA(TM) research tool represents the most complete tool available for the study of ovarian cancer.
Seahorse XF96 Extracellular Flux Analyzer
The Seahorse XF96 Analyzer is the first analytical instrument for the kinetic measurement of mitochondrial oxygen consumption and cytoplasmic glycolysis in a 96-well microplate. The easy-to-use instrument assays cells in minutes, using a label-free, non-destructive method. Measure mitochondrial function in primary cells, adherent cells, tumor and suspension cells and isolated mitochondria.
Labmatrix™ is a web-based software application for management of clinical, specimen and molecular assay data. With the ability to integrate these data sets in a tightly linked, highly annotated manner, Labmatrix™ is being used by multiple customers in the biopharmaceutical industry, academic and government research institutes for biomarker discovery, biobanking and translational clinical and genetic research.
About Cambridge Healthtech Institute (CHI)
Founded in 1992, Cambridge Healthtech Institute (http://www.chicorporate.com) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, academic, and niche service provider organizations. CHI's integrated life science portfolio of products and services includes Cambridge Healthtech Institute Conferences, Pharmaceutical Strategy Series, Barnett International, Insight Pharma Reports, Marketing Services, Meeting Planners, and Cambridge Healthtech Media Group, which includes numerous eNewsletters, Bio-IT World magazine, as well as Lead Generation Programs.
For more information, contact:
Cambridge Healthtech Institute
Cambridge Healthtech Institute